AU2001236798A1 - Optically-active nanoparticles for use in therapeutic and diagnostic methods - Google Patents

Optically-active nanoparticles for use in therapeutic and diagnostic methods

Info

Publication number
AU2001236798A1
AU2001236798A1 AU2001236798A AU2001236798A AU2001236798A1 AU 2001236798 A1 AU2001236798 A1 AU 2001236798A1 AU 2001236798 A AU2001236798 A AU 2001236798A AU 2001236798 A AU2001236798 A AU 2001236798A AU 2001236798 A1 AU2001236798 A1 AU 2001236798A1
Authority
AU
Australia
Prior art keywords
optically
therapeutic
diagnostic methods
active nanoparticles
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001236798A
Other versions
AU2001236798B2 (en
Inventor
Nancy J. Halas
Leon R. Hirsch
Jennifer L. West
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
William Marsh Rice University
Original Assignee
William Marsh Rice University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Marsh Rice University filed Critical William Marsh Rice University
Priority claimed from PCT/US2001/004155 external-priority patent/WO2001058458A1/en
Publication of AU2001236798A1 publication Critical patent/AU2001236798A1/en
Application granted granted Critical
Publication of AU2001236798B2 publication Critical patent/AU2001236798B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2001236798A 2000-02-08 2001-02-08 Optically-active nanoparticles for use in therapeutic and diagnostic methods Expired AU2001236798B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18110900P 2000-02-08 2000-02-08
US60/181,109 2000-02-08
PCT/US2001/004155 WO2001058458A1 (en) 2000-02-08 2001-02-08 Optically-active nanoparticles for use in therapeutic and diagnostic methods

Publications (2)

Publication Number Publication Date
AU2001236798A1 true AU2001236798A1 (en) 2001-11-01
AU2001236798B2 AU2001236798B2 (en) 2004-11-04

Family

ID=22662939

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001236798A Expired AU2001236798B2 (en) 2000-02-08 2001-02-08 Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU3679801A Pending AU3679801A (en) 2000-02-08 2001-02-08 Optically-active nanoparticles for use in therapeutic and diagnostic methods

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU3679801A Pending AU3679801A (en) 2000-02-08 2001-02-08 Optically-active nanoparticles for use in therapeutic and diagnostic methods

Country Status (6)

Country Link
EP (2) EP1263447B1 (en)
JP (2) JP5074652B2 (en)
AU (2) AU2001236798B2 (en)
CA (1) CA2399293C (en)
IL (2) IL151128A0 (en)
WO (1) WO2001058458A1 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001005586A1 (en) * 1999-07-16 2001-01-25 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
JP5074652B2 (en) † 2000-02-08 2012-11-14 ライスユニバーシティ Optically active nanoparticles used in therapeutic and diagnostic methods
US6685730B2 (en) * 2001-09-26 2004-02-03 Rice University Optically-absorbing nanoparticles for enhanced tissue repair
JP2005538033A (en) * 2001-12-04 2005-12-15 ナノスペクトラ バイオサイエンセズ，インク． Treatment of pathological conditions characterized by excessive or inappropriate angiogenesis
WO2005077330A1 (en) * 2004-02-17 2005-08-25 The University Of Melbourne Electromagnetic radiation addressable materials
FR2869803B1 (en) * 2004-05-10 2006-07-28 Nanobiotix Sarl ACTIVE PARTICLES, PREPARATION AND USES
CN1969183A (en) * 2004-06-17 2007-05-23 皇家飞利浦电子股份有限公司 Combined ultrasonic imaging and spectroscopic molecular analysis
JP4653983B2 (en) * 2004-08-23 2011-03-16 菊治 山下 Cancer treatment equipment that emits far infrared rays
WO2006027738A1 (en) * 2004-09-10 2006-03-16 Philips Intellectual Property & Standards Gmbh Compounds and methods for combined optical-ultrasound imaging
FR2877571B1 (en) * 2004-11-05 2007-04-13 Nanobiotix Sarl NANOPARTICLES WITH INTRACELLULAR TARGETING ELEMENT, PREPARATION AND USES
US20080045865A1 (en) * 2004-11-12 2008-02-21 Hanoch Kislev Nanoparticle Mediated Ultrasound Therapy and Diagnostic Imaging
US7999161B2 (en) * 2005-01-22 2011-08-16 Alexander Oraevsky Laser-activated nanothermolysis of cells
US20070065359A1 (en) * 2005-03-14 2007-03-22 Shiladitya Sengupta Nanocells for diagnosis and treatment of diseases and disorders
JP4911915B2 (en) * 2005-05-09 2012-04-04 トヨタ自動車株式会社 Target decomposition method and decomposition apparatus
JP2009533076A (en) * 2006-03-01 2009-09-17 ザ ジェネラル ホスピタル コーポレイション System and method for providing cell-specific laser therapy of atheroma by targeting light absorbers to macrophages
US20090087862A1 (en) * 2006-03-17 2009-04-02 Vivacta Ltd. Chemical Sensing Device
JP5364876B2 (en) * 2006-04-03 2013-12-11 国立大学法人東京工業大学 Virus particle-like structure and formulation containing the same
CN101490554A (en) * 2006-06-06 2009-07-22 维瓦克塔有限公司 Method for sensing a chemical
ES2725023T3 (en) 2006-10-12 2019-09-18 Galera Labs Llc Methods for the treatment of oral mucositis
FI20070162L (en) * 2007-02-27 2008-08-28 Teknillinen Korkeakoulu Method for controlled release of material from amphiphilic compounds and use of the method
US9493817B2 (en) 2007-03-05 2016-11-15 Genesis Research Institute, Inc. Decomposition method and decomposition apparatus for nucleic acid polymer
ITFI20070285A1 (en) * 2007-12-19 2009-06-20 Colorobbia Italiana Spa NANOSPHERE WITH EXTERNAL SURFACE IN NOBLE METALS.
JP5278872B2 (en) * 2008-05-02 2013-09-04 公立大学法人大阪府立大学 Gold nanofilm-coated liposome and method for producing the same
WO2010007803A1 (en) * 2008-07-17 2010-01-21 コニカミノルタエムジー株式会社 Nanoparticle labeling and system using the nanoparticle labeling
US20100113861A1 (en) * 2008-10-27 2010-05-06 Board Of Trustees Of The University Of Arkansas Metallic nanoparticles with coated shells and applications of same
JP5908396B2 (en) 2009-04-21 2016-04-26 イミュノライト・エルエルシー Non-invasive energy upconversion method and system for in situ photobiomodulation
EP2435125B1 (en) * 2009-05-26 2016-09-14 The General Hospital Corporation Apparatus for dermal delivery of a substance
ES2359411B1 (en) * 2009-10-19 2012-04-03 Universidad De Zaragoza METHOD OF AUTHENTICATION OF OBJECTS.
ES2637373T3 (en) 2010-08-27 2017-10-13 Sienna Biopharmaceuticals, Inc. Compositions and methods for directed thermomodulation
US9572880B2 (en) 2010-08-27 2017-02-21 Sienna Biopharmaceuticals, Inc. Ultrasound delivery of nanoparticles
US10994992B2 (en) 2011-01-20 2021-05-04 Technion Research & Development Foundation Limited Method and system for manipulating a cell
EP2691082B1 (en) * 2011-03-30 2016-01-13 GR Intellectual Reserve, LLC Novel gold-platinum based bi-metallic nanocrystal suspensions, electrochemical manufacturing processes therefor and uses for the same
KR101304427B1 (en) * 2011-04-12 2013-09-05 한국과학기술연구원 Recyclable porous bead - satellite nanoparticles composite and the fabrication method thereof
WO2013035739A1 (en) * 2011-09-05 2013-03-14 株式会社Ihi Thermotherapy material, thermotherapy system and thermotherapy method
WO2013048965A1 (en) 2011-09-26 2013-04-04 Galera Therapeutics, Llc Methods for treatment of diseases
EP2790682B1 (en) * 2011-12-16 2019-03-20 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
US20150125398A1 (en) * 2012-05-11 2015-05-07 University Of Iowa Research Foundation Multimodal imaging methods using mesoporous silica nanoparticles
CN108480620A (en) 2012-10-11 2018-09-04 纳诺康波西克斯公司 Nano silver piece composition and method
EP3091919A4 (en) * 2014-01-10 2017-09-20 Sebacia, Inc. Treatment intervals for use of compositions comprising energy absorbing materials for dermatological applications
US9622483B2 (en) 2014-02-19 2017-04-18 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039620B2 (en) 2014-02-19 2021-06-22 Corning Incorporated Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
GB201412935D0 (en) * 2014-07-21 2014-09-03 Univ Tartu Materials for use with hyperthermia treatment
WO2016189125A1 (en) 2015-05-28 2016-12-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
US10786569B2 (en) * 2015-07-31 2020-09-29 Wei Wu Lithographically defined nanoparticles for microwave absorption
RS60558B1 (en) 2015-08-11 2020-08-31 Galera Labs Llc Pentaaza macrocyclic ring complexes possessing oral bioavailability
IL269915B (en) 2017-04-13 2022-09-01 Galera Labs Llc Combination cancer immunotherapy with pentaaza macrocyclic ring complex
DE102017123919A1 (en) 2017-10-13 2019-04-18 Gna Biosolutions Gmbh Method and apparatus for lysing microorganisms
WO2019145541A1 (en) * 2018-01-29 2019-08-01 Endor Technologies, S.L. Metal nanoobjects for cosmetic use
JP2021031728A (en) * 2019-08-23 2021-03-01 国立大学法人東京工業大学 Noble metal recovery method
DK4103236T3 (en) * 2020-10-27 2023-11-13 Elucida Oncology Inc Folate receptor targeted nanoparticle drug conjugates and uses thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303636A (en) 1974-08-20 1981-12-01 Gordon Robert T Cancer treatment
US4106488A (en) 1974-08-20 1978-08-15 Robert Thomas Gordon Cancer treatment method
US4162282A (en) 1976-04-22 1979-07-24 Coulter Electronics, Inc. Method for producing uniform particles
US4310505A (en) 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4728575A (en) 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging
US4921706A (en) 1984-11-20 1990-05-01 Massachusetts Institute Of Technology Unilamellar lipid vesicles and method for their formation
US4983159A (en) 1985-03-25 1991-01-08 Rand Robert W Inductive heating process for use in causing necrosis of neoplasms at selective frequencies
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
IL79559A0 (en) 1986-07-29 1986-10-31 Univ Ramot Contrast agents for nmr medical imaging
US4728578A (en) 1986-08-13 1988-03-01 The Lubrizol Corporation Compositions containing basic metal salts and/or non-Newtonian colloidal disperse systems and vinyl aromatic containing polymers
US5213788A (en) * 1988-09-29 1993-05-25 Ranney David F Physically and chemically stabilized polyatomic clusters for magnetic resonance image and spectral enhancement
US5023139A (en) 1989-04-04 1991-06-11 Research Corporation Technologies, Inc. Nonlinear optical materials
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US5432260A (en) 1991-05-03 1995-07-11 Washington University High affinity mannose receptor ligands
DE4117782C2 (en) * 1991-05-28 1997-07-17 Diagnostikforschung Inst Nanocrystalline magnetic iron oxide particles, processes for their production and diagnostic and / or therapeutic agents
US5817089A (en) † 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
WO1995010777A1 (en) 1993-10-15 1995-04-20 Rakowicz Szulczynska Ewa M Detection and treatment of breast and gynecological cancer
EP0649667B1 (en) * 1993-10-20 2001-02-28 Antonella Aprile Carpenter Quantum energy therapeutic biostimulation apparatus
US5786214A (en) 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
GB9502065D0 (en) 1995-02-02 1995-03-22 Nycomed Imaging As Contrast media
JP2001520511A (en) 1995-12-08 2001-10-30 ザ ユーナヴァーサティ オブ アラバマ アト バーミングハム リサーチ ファンデーション Targeting adenovirus vector
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
DE19626096C1 (en) 1996-06-28 1997-06-19 Siemens Nixdorf Inf Syst Three dimensional image representation method using laser projector
US6162211A (en) † 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
US6344272B1 (en) * 1997-03-12 2002-02-05 Wm. Marsh Rice University Metal nanoshells
JP2001526650A (en) * 1997-04-29 2001-12-18 ニユコメド・イメージング・アクシエセルカペト Optical contrast agent
DE19726282A1 (en) * 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoscale particles with an iron oxide-containing core surrounded by at least two shells
US6165440A (en) 1997-07-09 2000-12-26 Board Of Regents, The University Of Texas System Radiation and nanoparticles for enhancement of drug delivery in solid tumors
US6183773B1 (en) † 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE60027578T2 (en) † 1999-07-16 2007-01-25 WM. Marsh Rice University, Houston Method of detecting bioanalytes using metallic nanoshells
WO2001005586A1 (en) † 1999-07-16 2001-01-25 Wm. Marsh Rice University Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery
JP5074652B2 (en) † 2000-02-08 2012-11-14 ライスユニバーシティ Optically active nanoparticles used in therapeutic and diagnostic methods
CN101437485A (en) 2006-05-09 2009-05-20 高露洁-棕榄公司 Oral care regimen
US20130247924A1 (en) 2012-03-23 2013-09-26 Mark Scatterday Electronic cigarette having a flexible and soft configuration

Similar Documents

Publication Publication Date Title
AU2001236798A1 (en) Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU3679801A (en) Optically-active nanoparticles for use in therapeutic and diagnostic methods
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2001267097A1 (en) Methods and devices for improving breathing in patients with pulmonary disease
AU2001296550A1 (en) Dermabrasion and skin care apparatus
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001263239A1 (en) Tissue discrimination and applications in medical procedures
AU2001281369A1 (en) Cardiac disease treatment and device
GB0109537D0 (en) Well treatment fluids and methods for the use thereof
AU2001238701A1 (en) Ultrasonic medical device and associated method
AU2001286902A1 (en) Patient analysis and risk reduction system and associated methods
IL157993A0 (en) Molecular conjugates for use in cancer treatment and methods for the preparation thereof
AU2001257069A1 (en) Photostimulaton treatment apparatus and methods for use
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU7122801A (en) New aporphine esters and their use in therapy
AU2001292797A1 (en) Metal complexes for use in medical and therapeutic applications
AU4765800A (en) Gadolinium complex tetramides and use in medical imaging
GB0011052D0 (en) Medical device and use thereof
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
AU2001253886A1 (en) Methylxanthines in the diagnosis and treatment of autistic disorder
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU2002232912A1 (en) Carbene porphyrins and carbene porphyrinoids for use in medical diagnosis and treatment
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease